Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000239985 | SCV000299136 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-06-17 | criteria provided, single submitter | clinical testing | This variant is a gross duplication of the genomic region encompassing exons 17-61 of the ATM gene. While the exact position of the duplicated exons cannot be determined from this data, the duplicated copy of this region is likely in tandem and in-frame, therefore preserving the integrity of the reading frame. This variant has been observed in trans with a pathogenic ATM variant in an affected individual (Invitae database). If in tandem, this variant leads to duplication of >2000 amino acid residues in the ATM protein, which likely interferes with proper protein folding and function. In summary, this is a gross duplication with uncertain impact on protein function. However, since it has been observed in an affected individual in a compound heterozygous state, it has been classified as a Likely Pathogenic. |